Viewing Study NCT05598528


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-02-22 @ 4:15 PM
Study NCT ID: NCT05598528
Status: RECRUITING
Last Update Posted: 2024-12-02
First Post: 2022-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Sponsor: Second Xiangya Hospital of Central South University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: XYEYY20220928
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER_GOV View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View